熱門資訊> 正文
ASLAN Pharmaceuticals申请为股东出售6190万股普通股
2024-06-13 04:41
- ASLAN Pharmaceuticals (NASDAQ:ASLN) filed a prospectus related to the offer and resale of up to 61,904,761 ordinary shares.
- This prospectus is not an offer to sell.
- Filing
More on ASLAN Pharmaceuticals
- ASLAN Pharmaceuticals announces receipt of Nasdaq notice
- Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals
- Historical earnings data for ASLAN Pharmaceuticals
- Financial information for ASLAN Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
